Last reviewed · How we verify
candidate vaccine, SCB-1019T — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
candidate vaccine, SCB-1019T (candidate vaccine, SCB-1019T) — Clover Biopharmaceuticals AUS Pty.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| candidate vaccine, SCB-1019T TARGET | candidate vaccine, SCB-1019T | Clover Biopharmaceuticals AUS Pty | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- candidate vaccine, SCB-1019T CI watch — RSS
- candidate vaccine, SCB-1019T CI watch — Atom
- candidate vaccine, SCB-1019T CI watch — JSON
- candidate vaccine, SCB-1019T alone — RSS
Cite this brief
Drug Landscape (2026). candidate vaccine, SCB-1019T — Competitive Intelligence Brief. https://druglandscape.com/ci/candidate-vaccine-scb-1019t. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab